United Therapeutics (UTHR) Return on Equity [ROE] (2010 - 2026)
United Therapeutics' Return on Equity [ROE] was 21.31% in Q2 2026, up 3.54 percentage points from 17.77% a year earlier and up 1.50 percentage points from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Return on Equity [ROE] (2010 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at United Therapeutics came in at 19.71%, up 0.48 percentage points from FY2024.
- Return on Equity [ROE] has now increased for four consecutive years, with a five-year change of +3.04 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was 19.23% in FY2024 (+0.96 pp), 18.27% in FY2023 (+1.65 pp), 16.61% in FY2022 (+3.67 pp) and 12.94% in FY2021 (-3.73 pp).
- The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] since Q4 2018.
- Compared with a year earlier, Return on Equity [ROE] has increased for three straight quarters, with an average year-over-year change of +1.02 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q1 2022 (a gain of 5.05 percentage points); the worst was Q4 2021 (a drop of 3.20 percentage points).
- Per Business Quant data, UTHR's Return on Equity [ROE] in the three quarters before Q2 2026 was 19.81% (Q1 2026), 19.50% (Q4 2025) and 18.48% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | United Therapeutics | 23.13 Bn | 12.62 Bn | 683.80 Mn | 21.31% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.31% |
| Mar 31, 2026 | 19.81% |
| Dec 31, 2025 | 19.50% |
| Sep 30, 2025 | 18.48% |
| Jun 30, 2025 | 17.77% |
| Mar 31, 2025 | 18.27% |
| Dec 31, 2024 | 19.05% |
| Sep 30, 2024 | 18.83% |
| Jun 30, 2024 | 19.38% |
| Mar 31, 2024 | 18.56% |
| Dec 31, 2023 | 16.84% |
| Sep 30, 2023 | 16.18% |
| Jun 30, 2023 | 16.55% |
| Mar 31, 2023 | 14.68% |
| Dec 31, 2022 | 15.54% |
| Sep 30, 2022 | 15.93% |
| Jun 30, 2022 | 14.85% |
| Mar 31, 2022 | 16.90% |
| Dec 31, 2021 | 12.22% |
| Sep 30, 2021 | 12.38% |
API Access
United Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();